• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病之痛:银屑病患者心血管风险综述

The heartbreak of psoriasis: a review of cardiovascular risk in patients with psoriasis.

作者信息

Benson Max M, Frishman William H

机构信息

From the *Departments of Medicine, New York Methodist Hospital, Brooklyn, New York; and †New York Medical College/Westchester Medical Center, Valhalla, New York.

出版信息

Cardiol Rev. 2015 Nov-Dec;23(6):312-6. doi: 10.1097/CRD.0000000000000048.

DOI:10.1097/CRD.0000000000000048
PMID:26440534
Abstract

Psoriasis is a common, chronic, autoimmune condition characterized by excessive growth and differentiation of keratinocytes that affects approximately 1% to 3% of the general population in the United States. Mounting evidence has led to an increasing awareness that psoriasis as a disease is more than "skin deep" and that it shares systemic manifestations with other chronic inflammatory diseases such as Crohn's and diabetes mellitus. Recent studies have not only shown an increased prevalence of cardiovascular risk factors in psoriasis but have also identified psoriasis as an independent risk factor for developing cardiovascular disease. This calls for an approach beyond managing traditional risk factors, which remain the standard guidelines at present.

摘要

银屑病是一种常见的慢性自身免疫性疾病,其特征为角质形成细胞过度增殖和分化,在美国约1%至3%的普通人群中受到影响。越来越多的证据表明,银屑病作为一种疾病,其影响不仅限于皮肤表面,还与其他慢性炎症性疾病如克罗恩病和糖尿病有共同的全身表现。最近的研究不仅表明银屑病患者心血管危险因素的患病率增加,还将银屑病确定为发生心血管疾病的独立危险因素。这就需要一种超越管理传统危险因素的方法,而传统危险因素目前仍是标准指南。

相似文献

1
The heartbreak of psoriasis: a review of cardiovascular risk in patients with psoriasis.银屑病之痛:银屑病患者心血管风险综述
Cardiol Rev. 2015 Nov-Dec;23(6):312-6. doi: 10.1097/CRD.0000000000000048.
2
Cardiovascular risk and psoriasis: beyond the traditional risk factors.心血管风险与银屑病:超越传统危险因素。
Am J Med. 2014 Jan;127(1):12-8. doi: 10.1016/j.amjmed.2013.08.013. Epub 2013 Oct 23.
3
[Psoriasis and atherothrombotic disease].[银屑病与动脉粥样硬化血栓形成性疾病]
Ugeskr Laeger. 2010 Jun 28;172(26):1983-6.
4
Psoriasis: the visible killer.银屑病:隐匿的杀手。
Rev Port Cardiol. 2014 Feb;33(2):95-9. doi: 10.1016/j.repc.2013.06.017. Epub 2014 Feb 10.
5
More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.不止于皮肤表面:动脉粥样硬化作为银屑病的一种全身表现。
Br J Dermatol. 2009 Jul;161(1):1-7. doi: 10.1111/j.1365-2133.2009.09281.x. Epub 2009 Jun 4.
6
[Patients with psoriasis have an increased risk of cardiovascular diseases].银屑病患者患心血管疾病的风险增加。
Ugeskr Laeger. 2012 May 21;174(21):1450-2.
7
The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity.“银屑病进行曲”:一个关于严重银屑病如何引发心血管合并症的概念。
Exp Dermatol. 2011 Apr;20(4):303-7. doi: 10.1111/j.1600-0625.2011.01261.x.
8
Psoriasis: a skin disease associated with increased cardiovascular risk.银屑病:一种与心血管风险增加相关的皮肤病。
Actas Dermosifiliogr. 2012 Sep;103(7):595-8. doi: 10.1016/j.ad.2012.01.006. Epub 2012 Mar 31.
9
Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.银屑病患者的心血管健康:一线临床医生概述
Ostomy Wound Manage. 2009 May 1;55(5):38-47.
10
Psoriasis and cardiovascular disorders.银屑病与心血管疾病。
G Ital Dermatol Venereol. 2016 Dec;151(6):678-693. Epub 2016 Sep 14.

引用本文的文献

1
COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study.银屑病患者接受系统治疗时接种 COVID-19 疫苗:一项前瞻性单中心研究。
Front Immunol. 2023 Mar 16;14:1107438. doi: 10.3389/fimmu.2023.1107438. eCollection 2023.
2
Prevalence and Predictors of Abdominal Aorta Calcification in Patients With Psoriasis-A Case Control Study.银屑病患者腹主动脉钙化的患病率及预测因素——一项病例对照研究
Front Med (Lausanne). 2022 Jun 30;9:890195. doi: 10.3389/fmed.2022.890195. eCollection 2022.
3
Management of psoriasis in pregnancy - a review of the evidence to date.
孕期银屑病的管理——迄今证据综述
Drugs Context. 2020 Mar 9;9. doi: 10.7573/dic.2019-11-6. eCollection 2020.
4
The first nation-wide study revealing epidemiologic data and life quality aspects of psoriasis in Romania.第一项揭示罗马尼亚银屑病流行病学数据和生活质量方面情况的全国性研究。
Exp Ther Med. 2019 Aug;18(2):900-904. doi: 10.3892/etm.2019.7652. Epub 2019 Jun 10.
5
Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis.银屑病和银屑病关节炎中的早期内皮祖细胞与血管僵硬。
Eur J Med Res. 2018 Nov 9;23(1):56. doi: 10.1186/s40001-018-0352-7.
6
Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.银屑病与心血管合并症:关注严重血管事件、心血管风险因素及治疗影响。
Int J Mol Sci. 2017 Oct 21;18(10):2211. doi: 10.3390/ijms18102211.
7
Indirect comparisons of the efficacy of subsequent biological agents in patients with psoriatic arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis.对肿瘤坏死因子抑制剂反应不足的银屑病关节炎患者中后续生物制剂疗效的间接比较:一项荟萃分析。
Clin Rheumatol. 2016 Jul;35(7):1795-803. doi: 10.1007/s10067-016-3204-2. Epub 2016 Feb 6.
8
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients.银屑病患者对生物制剂的偏好:心血管疾病患者对安全性的首要关注
PLoS One. 2015 Dec 3;10(12):e0144335. doi: 10.1371/journal.pone.0144335. eCollection 2015.